-
公开(公告)号:US06602519B1
公开(公告)日:2003-08-05
申请号:US09647117
申请日:2001-01-23
IPC分类号: A61K948
CPC分类号: C12N15/67 , A61K38/00 , C07K14/57581 , C12N15/79 , Y02A50/411
摘要: The present invention relates to the use of oxidized thymosin &bgr;4 in therapy, more particularly in the treatment of diseases or conditions associated with an inflammatory response of septic shock.
摘要翻译: 本发明涉及氧化的胸腺素β4在治疗中的用途,更具体地涉及治疗与败血性休克的炎性反应有关的疾病或病症。